chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: M
Vaccine: MNQ, TDAP
Symptoms: Vaccination site erythema, Vaccination site swelling
Clinical narrative: Case number PHHY2014US170974 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 543828) on 29 Dec 2014. This report refers to an 11 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M140143) and BOOSTRIX (other manufacturer, batch number: 9M9AA); both vaccines administered in the left arm on 08 Sep 2014. On an unknown date after vaccination, he experienced significant swelling and erythema of the entire upper arm where vaccines were given. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Body temperature increased, Injected limb mobility decreased, Injection site bruising, Injection site induration, Injection site oedema
Clinical narrative: Case number PHHY2014US171676 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 543866) on 29 Dec 2014. This report refers to a 13 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12102) intramuscularly in the right arm, ADACEL (other manufacturer, batch number: C4332BA) intramuscularly in the right arm, VARVIVAX (other manufacturer, batch number: J009033) subcutaneously in the left arm and GARDASIL (other manufacturer, batch number: J008423) intramuscularly in the left arm; all vaccines administered on 18 Aug 2014. On 19 Aug 2014 at 3:30 pm, her mother called and reported that the patient's lower arm where VARIVAX was given had slight swelling which was the size of a fifty cent piece and it was red and itchy. She was advised to put ice on the arm and to contact physician immediately if the symptoms increased. On 26 Aug 2014, her mother called in regarding the patient. She stated that after she spoke with the reporter, she called the doctor and the patient took BENADRYL as per doctor's advice. As the day progressed, the redness increased in size to the size of a pancake and became hard at the center. She also had a rash at the site and complained of pain, itchiness and she could not move her arm. She also had slight temperature of 100 degrees. Her mother attempted to call the doctor, but could not reach him and hence took the patient to the emergency room. She was put on prednisone twice QD and was told to take BENADRYL 25 mg thrice daily. At the time of reporting, the arm was slightly swollen and there was no pain. It looked like a bruise. She was able to move the arm. The mother was asked if the child had neomycin allergy, but she stated that she herself was allergic of NEOSPORIN and was unsure about the patient. The outcome of swelling and bruise was reported as condition unchanged and that of pain and injected limb mobility decreased was reported as complete recovery. The outcome of other events was not reported. The events were reported as non-serious. The causality of the events was not reported.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP, VARCEL
Symptoms: Injection site pain, Injection site pruritus, Injection site rash, Vaccination site swelling
Clinical narrative: Case number PHHY2014US171676 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 543866) on 29 Dec 2014. This report refers to a 13 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: M12102) intramuscularly in the right arm, ADACEL (other manufacturer, batch number: C4332BA) intramuscularly in the right arm, VARVIVAX (other manufacturer, batch number: J009033) subcutaneously in the left arm and GARDASIL (other manufacturer, batch number: J008423) intramuscularly in the left arm; all vaccines administered on 18 Aug 2014. On 19 Aug 2014 at 3:30 pm, her mother called and reported that the patient's lower arm where VARIVAX was given had slight swelling which was the size of a fifty cent piece and it was red and itchy. She was advised to put ice on the arm and to contact physician immediately if the symptoms increased. On 26 Aug 2014, her mother called in regarding the patient. She stated that after she spoke with the reporter, she called the doctor and the patient took BENADRYL as per doctor's advice. As the day progressed, the redness increased in size to the size of a pancake and became hard at the center. She also had a rash at the site and complained of pain, itchiness and she could not move her arm. She also had slight temperature of 100 degrees. Her mother attempted to call the doctor, but could not reach him and hence took the patient to the emergency room. She was put on prednisone twice QD and was told to take BENADRYL 25 mg thrice daily. At the time of reporting, the arm was slightly swollen and there was no pain. It looked like a bruise. She was able to move the arm. The mother was asked if the child had neomycin allergy, but she stated that she herself was allergic of NEOSPORIN and was unsure about the patient. The outcome of swelling and bruise was reported as condition unchanged and that of pain and injected limb mobility decreased was reported as complete recovery. The outcome of other events was not reported. The events were reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Abdominal discomfort, Asthenia, Blood pressure normal, Hyperhidrosis, Pallor
Clinical narrative: Case number PHHY2014US171269 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 543867) on 29 Dec 2014. This report refers to an 11 years old female patient. Her medical history and concomitant medications were not reported. She was vaccinated with MENVEO (batch number: A14021) and ADACEL (other manufacturer, batch number: C4506AC); both vaccines administered in the left arm on 10 Sep 2014. She also received a dose of GARDASIL (other manufacturer, batch number: J010668) in the right arm on 10 Sep 2014. On 10 Sep 2014, a few minutes after post vaccination, she started perspiring. Her mother escorted her to the water fountain for a drink. It was reported that perspiration persisted and hence her mother informed the reception staff. The patient was escorted to the triage room. She was pale, weak, damp all over from sweat, very quiet and stated that her stomach felt funny. She was laid supine on examination table. Her vital signs were stable. She drank about half cup of water and a while later had another half cup. Damp cloth was applied to her forehead and primary care physician (PCP) was notified. She evaluated the patient. It was confirmed later that she was feeling better and skin colour improved. Her blood pressure was checked and it was normal. After another 5 minutes, she sat upright and again blood pressure was re-checked and the results were normal. She was advised to contact PCP in case of any concerns or questions. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the event was not reported.
Age: 44.0
Sex: F
Vaccine: HEPA, MNQ, TYP, VARCEL
Symptoms: Dizziness, Injection site rash, Metabolic function test
Clinical narrative: Case number PHHY2014US171671, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 543941) website on 29 Dec 2014. This report refers to a 44 year old female patient. Medical history was not reported. Past medications included penicillin G, aspirin and ibuprofen. No concomitant medication was reported. The patient was vaccinated with MENVEO (batch number: A14044), HAVRIX (other manufacturer, batch number: GX2la) TYPHIM VI (other manufacturer, batch number: J05011) and VARIVAX (other manufacturer, batch number: L013905) all in right arm on 10 Sep 20114. On 11 Sep 2014 (within 24 hours of vaccination), she developed rash at right upper outer arm. On 14 Sep 2014 (in the morning), she experienced dizziness which went away. On 15 Sep 2014, she again experienced some light headedness. A complete metabolic test was performed (no result given). Treatment was rendered with BENADRYL at a dose of 25 mg at an interval of 4 hours. Final outcome of these events was unknown. These events were reported as non-serious. Causality of these events was not reported.
Age: 11.0
Sex: M
Vaccine: HEPA, MNQ, TDAP
Symptoms: Erythema, Rash, Urticaria
Clinical narrative: Case number PHHY2014US171791, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 543948) website on 29 Dec 2014. This report refers to an 11 year old male patient. Historical condition was not reported. Concomitant medications include rizatriptan benzoate, naproxen sodium, and amitriptyline HCL. He was vaccinated with MENVEO (batch number: M14023) intramuscularly in right arm, HAVRIX (batch number T9J3M) intramuscularly in right arm and BOOSTRIX (batch number: AC52B097AA) intramuscularly in left arm on 12 Sep 2014. On 14 Sep 2014, he experienced urticaria, rash and area of redness on the right arm at a diameter of 8 x 6 cm. Final outcome of these events was unknown. Events were reported as non-serious. Causality was not reported.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site pruritus, Injection site swelling
Clinical narrative: Case number PHHY2014US171015, is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 544488) on 29 Dec 2014. This report refers to a 17 years old female patient. Medical history and concomitant medications was not reported. She was vaccinated with MENVEO (batch number: M14067) intramuscularly into left arm on 16 Sep 2014. On 17 Sep 2014, one day after vaccination, the patient experienced erythema and swelling at the injection site of area about 6 cm associated with itching. Outcome of the event was unknown. The case was assessed as non-serious. Causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Urticaria
Clinical narrative: Case number PHHY2014US171419 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 544668) website on 29 Dec 2014. This report refers to an 11 year old male patient. His past medical history and concomitant medications were not reported. On 18 Sep 2014, he was vaccinated with MENVEO (batch number: M14042) intramuscularly into his left arm, with ADACEL (batch number: U4689BA) intramuscularly into his left arm and with GARDASIL (batch number: K004205) intramuscularly into his right arm. On 19 Sep 2014, he developed hives without other symptoms. The final outcome of the event was unknown. The event was reported as non serious and causality of the event was not reported.
Age: 11.0
Sex: M
Vaccine: FLUN4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site induration, Injection site reaction, Injection site warmth, Rash erythematous
Clinical narrative: Case number PHHY2014US170687 is an initial spontaneous report received from a healthcare professional via the Vaccine Adverse Event Reporting System (VAERS ID: 544738) web site on 29 Dec 2014. This report refers to a 11 year old male patient. His past medical history included premature birth at 26 weeks and concomitant medications were not reported. On 16 Sep 2014, he was vaccinated with MENVEO (batch number: A14044) intramuscularly into his right arm, with FLUMIST (other manufacturer, batch number: not reported) intranasally and with BOOSTRIX (other manufacturer, batch number: 55R2L) intramuscularly into his left arm. On 17 Sep 2014, he developed a light red rash on his upper arm which increased in size. On 18 Sep 2014, he visited the physician's office. He had warmth, erythema and induration at the right deltoid approximately of the size 8 x 7 cm. He had no fever or pain. The patient was advised to monitor the area and return to the office if increased. The final outcome of the events was complete recovery. The events were reported as non serious and causality of the events was not reported.
Age: 16.0
Sex: F
Vaccine: HEPA, MNQ, MNQ
Symptoms: No adverse event, Product preparation error
Clinical narrative: Case number PHYY2014US171607, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 544885) website on 29 Dec 2014. This report refers to a 16-year-old female patient. Historical conditions were not reported. The patient was well at the time of vaccination. Concomitant medications included HAVRIX (batch number: 5324E). She was administered MENVEO (batch number: not reported) reconstituted with a diluent of MENACTRA (batch number: U4658AA) intramuscularly on 11 Sep 2014. No adverse event was reported following the maladministration.
Age: 10.0
Sex: F
Vaccine: MNQ
Symptoms: Erythema, Induration, Skin warm, Tenderness
Clinical narrative: Case number PHHY2014US171233, is an initial spontaneous report received from the Vaccine Adverse Events Reporting System (reference number: 544903) on 29 Dec 2014. This report refers to a 10 years old female patient. Her medical history was not reported. Her historical drugs included administration of penicillin, cephalosporins, SEPTRA and SINGULAIR. Her concomitant medications included administration of multi-vit and probiotic. She was vaccinated with MENVEO (batch number: M14024) intramuscularly in left arm on 10 Aug 2014. On 18 Aug 2014, she presented with 40 by 60 mm warm, tender, firm induration with overlying erythema. The outcome of the event was reported as complete recovery. The events were reported as non-serious and causality of the events was not reported.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Syncope
Clinical narrative: Case number PHYY2014US159689 is an initial spontaneous report received via the Vaccine Adverse Event Reporting System (reference number: 545016) website on 28 Nov 2014. This report refers to an 18 years old female patient. Her current condition included PENICILLIN allergy and asthma. Her concomitant medications were not reported. She was vaccinated with MENINGOCOCCAL ACYW-135 vaccine (manufacturer and batch number: not reported) on an unknown date. It was reported that after vaccination she experienced syncope. The outcome, seriousness and causality of the event was not reported. She was further vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) in the left arm and RABIVAC (batch number: not reported) in the right arm; both vaccines administered intramuscularly on 22 Sep 2014 following which she experienced spinal pain (see related case number: PHHY2014US159680).
Age: 11.0
Sex: F
Vaccine: DTAP, HPV4, MNQ
Symptoms: Abdominal pain upper
Clinical narrative: Case number PHHY2014US171330 is an initial spontaneous report received from a nurse via the Vaccine Adverse Event Reporting System (VAERS ID: 545188) website on 29 Dec 2014. This report refers to a 11 year old female patient. Her past medical history and concomitant medications were not reported. On 16 Sept 2014, she was vaccinated with MENVEO (conjugated CRM 197, batch number: not reported), with GARDASIL (other manufacturer, batch number: not reported) intramuscularly and with tetanus, diphtheria and acellular pertussis vaccine (other manufacturer, batch number: not reported). On the same day after the vaccination, she experienced a stomach ache. There was no treatment given for the event and no lab investigations were performed. The outcome of the event was unknown. The event was reported as non serious and causality of the event was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Asthenia, Dizziness, Feeling of body temperature change, Head discomfort, Mononucleosis heterophile test negative
Clinical narrative: Case number PHHY2014US171765 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 545281) website on 29 Dec 2014. This report refers to an 11 year old female patient. Her current conditions included tonsillitis diagnosed on 18 Sep 2014 and concomitant medications were not reported. On 19 Sep 2014, she was vaccinated with MENVEO (batch number: X14045) into her left arm and with BOOSTRIX (other manufacturer, batch number: 4JL44) into her right arm. On 20 Sep 2014, she developed dizziness, weakness, hot and cold feeling, low grade fever, pressure in the back of her head and stiff neck. She was treated with ibuprofen at a dose of 600 mg every 6 hours and with butalbital / acetaminophen. On 22 Sep 2014, a test for mononucleosis was negative. On an unspecified date, the patient visited the emergency room. The final outcome of the events was condition unchanged. The events were reported as non serious and causality of the events was not reported.
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Musculoskeletal stiffness, Pyrexia
Clinical narrative: Case number PHHY2014US171765 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 545281) website on 29 Dec 2014. This report refers to an 11 year old female patient. Her current conditions included tonsillitis diagnosed on 18 Sep 2014 and concomitant medications were not reported. On 19 Sep 2014, she was vaccinated with MENVEO (batch number: X14045) into her left arm and with BOOSTRIX (other manufacturer, batch number: 4JL44) into her right arm. On 20 Sep 2014, she developed dizziness, weakness, hot and cold feeling, low grade fever, pressure in the back of her head and stiff neck. She was treated with ibuprofen at a dose of 600 mg every 6 hours and with butalbital / acetaminophen. On 22 Sep 2014, a test for mononucleosis was negative. On an unspecified date, the patient visited the emergency room. The final outcome of the events was condition unchanged. The events were reported as non serious and causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site pain, Injection site pruritus, Peripheral swelling
Clinical narrative: Case number PHHY2014US171427 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 545306) website on 29 Dec 2014. This report refers to an 11 year old male patient. His current conditions included asthma and seasonal allergies. His concomitant medications included albuterol sulfate and cetirizine hydrochloride. On 15 Aug 2014, he was vaccinated with MENVEO (batch number: M14030) into his left arm, with ADACEL (batch number: C4137AA) into his left arm and with GARDASIL (batch number: J015378) into his right arm. On 17 Aug 2014, his left arm was swollen after the vaccinations. He was taken to the ER two days after the vaccinations due to injection site itching and pain. He was treated with BENADRYL. The final outcome of the events was complete recovery. The events were reported as non serious and causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: MNQ
Symptoms: Injection site erythema
Clinical narrative: Case number PHHY2014US171474 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 545567) on 29 Dec 2014. This report refers to an 11 years old male patient. His medical history and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M13014) intramuscularly in the right arm on 26 Sep 2014. On 26 Sep 2014, he experienced 11 x 11 cm redness in the site of right arm. The event outcome was unknown. The event was reported as non-serious. The causality of the event was not reported.
Age: 11.0
Sex: M
Vaccine: FLU4, MNQ, TDAP
Symptoms: Erythema, Pain, Pruritus, Swelling
Clinical narrative: Case number PHHY2014US171435 is an initial spontaneous report received from a health care professional via the Vaccine Adverse Event Reporting System (VAERS ID: 545822) website on 29 Dec 2014. This report refers to an 11 year old male patient. His past medical history and concomitant medications were not reported. On 17 Sep 2014, he was vaccinated with MENVEO (batch number: M14044) intramuscularly into his right arm, with FLUARIX (other manufacturer, batch number: 2L752) intramuscularly into his right arm and with BOOSTRIX (batch number: 9M9AA) intramuscularly into his left arm. On an unspecified date after the vaccination, the patient developed swelling, pain, redness and itching. The final outcome of the events was complete recovery. The events were reported as non serious and causality of the events was not reported.
Age: 16.0
Sex: M
Vaccine: HPV4, MNQ
Symptoms: Lip swelling
Clinical narrative: Case number PHHY2014US170541, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 545829) website on 29 Dec 2014. This report refers to a 16 year old male patient. Medical history was not reported. Concurrent conditions included allergies to grass, pollens, trees, milk, egg and wheat. No concomitant medication was reported. He was vaccinated with MENVEO (batch number: M14030) and GARDASIL (batch number: K006117) both intramuscularly on 24 Sep 2014. On the same day approximately 45 minutes after vaccination, he developed moderate severe swelling of upper and lower lips. He was taken to emergency room due to the event. Final outcome of the event was reported as complete recovery. The event was reported as non-serious. Causality was not reported.
Age: 26.0
Sex: F
Vaccine: MEN
Symptoms: Chills, Headache, Influenza like illness, Nausea, Pain
Clinical narrative: Case number PHHY2014US159808, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 545900) website on 28 Nov 2014. This report refers to a 26-year-old female patient. Current condition included asthma. She was vaccinated with MENINGOCOCCAL ACYW vaccine (manufacturer and batch number: not reported) intramuscularly in the left arm on 29 Sep 2014. On the same date, after vaccination she had extreme body ache, headache, nausea, swelling of arm where vaccine was administered, fever, chills, poor regulation of temperature and flu-like symptoms for more than 48 hours. The outcome of the events reported as recovered. The events reported as non-serious. The causality of the events was not reported.
Age: 26.0
Sex: F
Vaccine: MEN
Symptoms: Pyrexia, Temperature regulation disorder, Vaccination site swelling
Clinical narrative: Case number PHHY2014US159808, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 545900) website on 28 Nov 2014. This report refers to a 26-year-old female patient. Current condition included asthma. She was vaccinated with MENINGOCOCCAL ACYW vaccine (manufacturer and batch number: not reported) intramuscularly in the left arm on 29 Sep 2014. On the same date, after vaccination she had extreme body ache, headache, nausea, swelling of arm where vaccine was administered, fever, chills, poor regulation of temperature and flu-like symptoms for more than 48 hours. The outcome of the events reported as recovered. The events reported as non-serious. The causality of the events was not reported.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Pruritus, Rash
Clinical narrative: Case number PHHY2014US171396, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 546275) website on 29 Dec 2014. This report refers to a 17 year old female patient. Medical history and concurrent condition was not reported. On 29 Sep 2014, she was vaccinated with MENVEO (batch number: M13017) intramuscular into right arm. On 30 Sept 2014, she developed rash and itchy that started on arms and spread to legs. Treatment medication included BENADRYL, ZANTAC and oatmeal bath to relieve itch. Final outcome of the events was unknown. Causality assessment was not reported. Events were reported as non-serious.
Age: 12.0
Sex: F
Vaccine: MNQ
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: Case number PHHY2014US171407, is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 546458) on 29 Dec 2014. This report refers to a 12 years old female patient. Medical history and concomitant medications were not reported. On 25 Sep 2014, she was inadvertently vaccinated with MENVEO (batch number: M14021) into right arm which was not in due to receive. No adverse event was reported following this medication error.
Age: 13.0
Sex: F
Vaccine: HPV4, MNQ, TDAP
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Case number PHHY2014US171519, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 546868) website on 29 Dec 2014. This report refers to a 13-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. She was vaccinated with MENVEO (batch number: M14042), along with GARDASIL (batch number: K004204) intramuscularly into the left arm and BOOSTRIX (batch number: 5XP4D) intramuscularly into the right arm on 22 Sep 2014. On 23 Sep 2014, the patient developed localized redness and swelling at right and left deltoid. The patient took BENADRYL and applied warm compress. The final outcome of the events was unknown. The events were reported as non-serious. Causality was not reported.
Age: 19.0
Sex: M
Vaccine: FLUX, MNQ
Symptoms: Nausea, Nystagmus, Vertigo
Clinical narrative: Case number PHHY2014US163040, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 547047) website on 28 Nov 2014. This report refers to a 19 year old male patient. His medical history and concomitant medication were not reported. He was vaccinated with MENVEO, (batch number: A14006) intramuscularly in left arm and seasonal Influenza vaccine (manufacturer and batch number: not reported) on 02 Oct 2014. On 03 Oct 2014, he experienced sudden onset of vertigo, nausea and bilateral horizontal nystagmus. The patient was taken to emergency room for medical support. Final outcome of the events was complete recovery. Events were reported as non-serious. Causality of the events was not reported.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Crying, Induration, Peripheral swelling, Rash, Skin warm
Clinical narrative: Case number PHHY2014US171462, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 547129) website on 29 Dec 2014. This report refers to a 17-year-old female patient. Current conditions included asthma which was mild intermittent and eczema. She was vaccinated with MENVEO (batch number: X14067) in the left arm on 30 Sep 2014. On 01 Oct 2014, after vaccination her arm was swollen, warmth, had rash, indurated, tender and she was crying. Her left arm at axilla measured 30 cm whereas right arm at axilla measured 29. She visited the emergency room and started on AUGMENTIN. She was in process of recovering. The events reported as non-serious. The causality of the events was not reported.
Age: 17.0
Sex: F
Vaccine: MNQ
Symptoms: Tenderness
Clinical narrative: Case number PHHY2014US171462, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (reference number: 547129) website on 29 Dec 2014. This report refers to a 17-year-old female patient. Current conditions included asthma which was mild intermittent and eczema. She was vaccinated with MENVEO (batch number: X14067) in the left arm on 30 Sep 2014. On 01 Oct 2014, after vaccination her arm was swollen, warmth, had rash, indurated, tender and she was crying. Her left arm at axilla measured 30 cm whereas right arm at axilla measured 29. She visited the emergency room and started on AUGMENTIN. She was in process of recovering. The events reported as non-serious. The causality of the events was not reported.
Age: 11.0
Sex: M
Vaccine: FLUN4, HPV4, MNQ, TDAP
Symptoms: Injection site swelling, Pain, Swelling, Vaccination site erythema, Vaccination site pain
Clinical narrative: Case number PHHY2014US171692 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 547853) on 29 Dec 2014. This report refers to an 11 years old male patient. His medical history included obesity and concomitant medications were not reported. He was vaccinated with MENVEO (batch number: M14042) in the right arm, GARDASIL (other manufacturer: K004204) intramuscularly in the right arm, FLUMIST QUADRIVALENT (other manufacturer, batch number: CJ2003) via intranasal route and BOOSTRIX (other manufacturer, batch number: N4L77) in the left arm; all vaccines administered on 30 Sep 2014. On 30 Sep 2014, he had reaction to GARDASIL. He had a bump at the injection site which started growing that night. He visited emergency room on 02 Oct 2014 and pain and swelling was present at the visit. His body temperature was 98 F and he also had erythematous halo around both vaccination site which was mildly tender (not exquisitely) and of size 8.5 x 7. he was treated with BENADRYL. The events outcome was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 18.0
Sex: M
Vaccine: FLU4, HEPA, MNQ, PPV
Symptoms: Asthenia, Chills, Hypoaesthesia, Nausea, Pain
Clinical narrative: Case number PHHY2014US171773, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 548184) website on 29 Dec 2014. This report refers to an 18 year old male patient. Medical history was not reported. Concurrent conditions included coarctation of the aorta, ventricular septal defect and atrial septal defect. He was vaccinated with MENVEO (batch number: A14044) intramuscularly in left arm, HAVRIX (other manufacturer, batch number: 5RB2H) intramuscularly in left arm, FLUZONE (other manufacturer, batch number: UI187AB) intramuscularly in right arm and PNEUMOVAX (other manufacturer, batch number: J014401) intramuscularly in right arm on 09 Sep 2014. On the same day after vaccination, the patient developed numbness in arm, pain, weakness, vomiting, nausea and chills. He was taken to emergency room. Final outcome of these events was reported as complete recovery. Events were reported as non-serious. Causality was not reported.
Age: 18.0
Sex: M
Vaccine: FLU4, HEPA, MNQ, PPV
Symptoms: Vomiting
Clinical narrative: Case number PHHY2014US171773, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 548184) website on 29 Dec 2014. This report refers to an 18 year old male patient. Medical history was not reported. Concurrent conditions included coarctation of the aorta, ventricular septal defect and atrial septal defect. He was vaccinated with MENVEO (batch number: A14044) intramuscularly in left arm, HAVRIX (other manufacturer, batch number: 5RB2H) intramuscularly in left arm, FLUZONE (other manufacturer, batch number: UI187AB) intramuscularly in right arm and PNEUMOVAX (other manufacturer, batch number: J014401) intramuscularly in right arm on 09 Sep 2014. On the same day after vaccination, the patient developed numbness in arm, pain, weakness, vomiting, nausea and chills. He was taken to emergency room. Final outcome of these events was reported as complete recovery. Events were reported as non-serious. Causality was not reported.
Age: 17.0
Sex: F
Vaccine: FLU4, MNQ
Symptoms: Injection site erythema, Vaccination site pain, Vaccination site swelling
Clinical narrative: Case number PHHY2014US171776, is an initial spontaneous report received from the Vaccine Adverse Event Reporting System (VAERS, reference number: 548251) website on 29 Dec 2014. This report refers to a 17 year old female patient. Historical condition and concomitant medication were not reported. She was vaccinated with MENVEO (batch number: A14025) and FLUARIX (other manufacturer, batch number: 2A2KX) both in left arm on 30 Sep 2014. On 03 Oct 2014, she experienced vaccination site redness, swelling and tenderness. Treatment was rendered with cool compresses, ibuprofen and BENADRYL. Final outcome of these events was unknown. Events were reported as non-serious. Causality was not reported.
Age: 13.0
Sex: F
Vaccine: FLU3, MNQ
Symptoms: Injection site swelling
Clinical narrative: Case number PHHY2015US19543 is an initial spontaneous report received from Vaccine Adverse Event Reporting System (VAERS ID: 548584) on 03 Feb 2015. This report refers to a 13 years old female patient. Her medical history and concomitant medications were not reported. Her vaccination history included administration of unspecified vaccines in the past following which she had arm swelling (she could not recall which vaccine she received). She was vaccinated with MENVEO (batch number: M14056) and FLUARIX (other manufacturer, batch number: 5J9E9); both vaccines administered intramuscularly in the right arm on 16 Oct 2014. On 16 Oct 2014, she had right arm swelling in the deltoid approximately 45 minutes after vaccination. Ice was applied to the right deltoid area. The event outcome was reported as complete recovery. The event was reported as non-serious. The causality of the event was not reported.
Age: 17.0
Sex: F
Vaccine: FLU4, MNQ
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Case number PHHY2015US018156, is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS reference number: 549411) website on 03 Feb 2015. This report refers to a 17-year-old female patient. Past medical history was not reported. Current condition of the patient included the tinea corporis, attention deficit disorder (ADD) and bipolar disorder. Concomitant medication included ZOLOFT. On 21 Oct 2014, she was vaccinated with MENVEO (batch number: M14056) along with FLUARIX (other manufacturer, batch number: 9G57F) intramuscularly in the left arm. It was reported that within 24 hours of the vaccinations, the patient experienced redness, swelling and pain at the site of vaccination. The final outcome of the events was reported as complete recovery. The events were reported as non-serious. The causality of the events was not reported.
Age: 13.0
Sex: M
Vaccine: FLUX, MEN
Symptoms: Arthralgia, Headache, Pain, Pain in extremity, Peripheral swelling
Clinical narrative: Case number PHHY2015US012874 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 552301) on 06 Jan 2015. This report refers to a 13 years old male patient. His medical history included natural growing pains. His current conditions were allergy to monosodium glutamate (MSG) of food. His concomitant medications were not reported. His vaccination history included DTP (other manufacturer, batch number: not reported) following which he had slight headache. He was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) and meningococcal vaccine (manufacturer and batch number: not reported and hence conservatively coded as meningococcal ACYW-135 vaccine INN); both vaccines administered in the left arm on 26 Sep 2014. On 26 Sep 2014, he had a light reaction which was further described as bumps and it got worse since he was scratching. The bumps turned to welts on an unknown date. Later they got pretty bad and he took oat meal (avena sativa) bath and BENADRYL which calmed it down. There was intense itching and visible hives which were growing and multiplying. His feet; especially thumbs were hurting because they were swollen and his joints were aching and it hurt to walk. He had no fever. He checked with nurse who advised him to visit emergency room if problems continued. He did not miss school. At the time of reporting, hives went and no BENADRYL was required. It was reported that soles of his feet were swollen and tender and he had a headache. The outcome of hives was reported as complete recovery, feet swelling, tenderness and headache were reported as condition unchanged and that of other events were reported as unknown. The events were reported as non-serious. The causality of the events was not reported.
Age: 13.0
Sex: M
Vaccine: FLUX, MEN
Symptoms: Rash, Tenderness, Urticaria
Clinical narrative: Case number PHHY2015US012874 is an initial spontaneous report received via Vaccine Adverse Event Reporting System (VAERS ID: 552301) on 06 Jan 2015. This report refers to a 13 years old male patient. His medical history included natural growing pains. His current conditions were allergy to monosodium glutamate (MSG) of food. His concomitant medications were not reported. His vaccination history included DTP (other manufacturer, batch number: not reported) following which he had slight headache. He was vaccinated with seasonal influenza vaccine (manufacturer and batch number: not reported) and meningococcal vaccine (manufacturer and batch number: not reported and hence conservatively coded as meningococcal ACYW-135 vaccine INN); both vaccines administered in the left arm on 26 Sep 2014. On 26 Sep 2014, he had a light reaction which was further described as bumps and it got worse since he was scratching. The bumps turned to welts on an unknown date. Later they got pretty bad and he took oat meal (avena sativa) bath and BENADRYL which calmed it down. There was intense itching and visible hives which were growing and multiplying. His feet; especially thumbs were hurting because they were swollen and his joints were aching and it hurt to walk. He had no fever. He checked with nurse who advised him to visit emergency room if problems continued. He did not miss school. At the time of reporting, hives went and no BENADRYL was required. It was reported that soles of his feet were swollen and tender and he had a headache. The outcome of hives was reported as complete recovery, feet swelling, tenderness and headache were reported as condition unchanged and that of other events were reported as unknown. The events were reported as non-serious. The causality of the events was not reported.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: On left arm (back) swelling, warm, redness, size of lemon. Noticed around 8 am on Wednesday May 11th. Also went to doctor's to look at.
Age: 66.0
Sex: F
Vaccine: VARZOS, VARZOS
Symptoms: Erythema, Peripheral swelling, Skin warm
Clinical narrative: On left arm (back) swelling, warm, redness, size of lemon. Noticed around 8 am on Wednesday May 11th. Also went to doctor's to look at.
Age: 17.0
Sex: F
Vaccine: TYP
Symptoms: Incorrect dose administered, Syringe issue
Clinical narrative: PT WAS ADMINISTERED AN INCOMPLETE DOSE OF THE VACCINE. THE INTERN THAT ADMINISTERED THE VACCINE APPROXIMATED THAT 1/4 OF THE DOSE LEAKED OUT OF THE SYRINGE DURING INJECTION AND WAS NOT ADMINISTERED TO THE PT. THE SYRINGE FROM THE MANUFACTURER MAY HAVE BEEN COMPROMISED BEFORE ADMISTRATION. THE PHARMACIST INFORMED THE PT THEY WOULD CONTACT THE MANUFACTURER TO DETERMINE IF ANOTHER DOSE WOULD BE NEEDED.
Sex: F
Vaccine: HPV4
Symptoms: Unevaluable event
Clinical narrative: This spontaneous report was received from an unspecified reporter via an online post that refers to an unspecified number patients of female patients of unknown age. Information regarding the patients' medical history and current condition were not provided. The online article states that patients were vaccinated with GARDASIL and then developed chronic health problems (adverse event), several hundred young women had died and thousands more were permanently disabled. There were cases of sudden death following the vaccination. Syncope was also mentioned to be the most common adverse reaction after use of GARDASIL. The outcome of the adverse event, disability and syncope was unknown. The causality assessment was not provided. Upon internal review, sudden death and disability was considered to be medically significant. Permanent disability was considered to have caused significant incapacity/disability. The case is linked to 1605USA011079 (same reporter link). Additional information has been requested.
Age: 0.71
Sex: F
Vaccine: RV5
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: Vaccine was given at age 37 4/7 weeks. Not to be administered over 32 weeks of age.
Age: 40.0
Sex: M
Vaccine: FLU4, HEP, HEPA
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: Pediatric dose Hep A administered vs adult dose. No adverse effects noted. Repeat adult dose given on 5-18-2016.
Age: 14.0
Sex: M
Vaccine: HPV9
Symptoms: Activities of daily living impaired, Dyskinesia, Electromyogram abnormal, Injected limb mobility decreased, Injection site pain
Clinical narrative: Left shoulder pain. This is his nondominant shoulder. His pain began shortly after receiving his HPV vaccine on December 29, 2016. His pain is more periscapular and in the area of the upper trapezius. He notes the arm feels very weak now he has a hard time forward flexing or abducting the shoulder. He has been swimming competitively for senior high school and is unable to do so due to the pain and weakness. His pain does not radiate. He does not think his grip has been affected. He does have more pain sometimes at night. He woke this morning with pain he thinks he may have slept on his left side, which is not usual for him. He has no numbness or tingling. He's had no swelling. He has no history of similar symptoms. He has no history of trauma to the shoulder that he can recall. Patient diagnosed with Parsonage-Turner Syndrome (brachial neuritis) by Musculoskeletal Specialist.  He was referred onto Neurology.  Diagnosis confirmed by EMG.  Patient was admitted to the hospital and received two rounds of IVIG on 3/7/2015.  Patient continues to have slightly diminished muscle bulk of the left shoulder compared to the right. At most recent evaluation on 3/28/2016 he continues to have mild scapular winging when doing a wall pushup and has mild scapular dyskinesia with slow controlled shoulder abduction.  Full-strength with resisted internal and external rotation and supraspinatus testing, subcapsular slipped off test, shoulder flexion and abduction.  Full biceps and triceps strength.
Age: 14.0
Sex: M
Vaccine: HPV9
Symptoms: Injection site reaction, Muscle atrophy, Muscular weakness, Neuralgic amyotrophy, Radiculitis brachial
Clinical narrative: Left shoulder pain. This is his nondominant shoulder. His pain began shortly after receiving his HPV vaccine on December 29, 2016. His pain is more periscapular and in the area of the upper trapezius. He notes the arm feels very weak now he has a hard time forward flexing or abducting the shoulder. He has been swimming competitively for senior high school and is unable to do so due to the pain and weakness. His pain does not radiate. He does not think his grip has been affected. He does have more pain sometimes at night. He woke this morning with pain he thinks he may have slept on his left side, which is not usual for him. He has no numbness or tingling. He's had no swelling. He has no history of similar symptoms. He has no history of trauma to the shoulder that he can recall. Patient diagnosed with Parsonage-Turner Syndrome (brachial neuritis) by Musculoskeletal Specialist.  He was referred onto Neurology.  Diagnosis confirmed by EMG.  Patient was admitted to the hospital and received two rounds of IVIG on 3/7/2015.  Patient continues to have slightly diminished muscle bulk of the left shoulder compared to the right. At most recent evaluation on 3/28/2016 he continues to have mild scapular winging when doing a wall pushup and has mild scapular dyskinesia with slow controlled shoulder abduction.  Full-strength with resisted internal and external rotation and supraspinatus testing, subcapsular slipped off test, shoulder flexion and abduction.  Full biceps and triceps strength.
Age: 14.0
Sex: M
Vaccine: HPV9
Symptoms: Winged scapula
Clinical narrative: Left shoulder pain. This is his nondominant shoulder. His pain began shortly after receiving his HPV vaccine on December 29, 2016. His pain is more periscapular and in the area of the upper trapezius. He notes the arm feels very weak now he has a hard time forward flexing or abducting the shoulder. He has been swimming competitively for senior high school and is unable to do so due to the pain and weakness. His pain does not radiate. He does not think his grip has been affected. He does have more pain sometimes at night. He woke this morning with pain he thinks he may have slept on his left side, which is not usual for him. He has no numbness or tingling. He's had no swelling. He has no history of similar symptoms. He has no history of trauma to the shoulder that he can recall. Patient diagnosed with Parsonage-Turner Syndrome (brachial neuritis) by Musculoskeletal Specialist.  He was referred onto Neurology.  Diagnosis confirmed by EMG.  Patient was admitted to the hospital and received two rounds of IVIG on 3/7/2015.  Patient continues to have slightly diminished muscle bulk of the left shoulder compared to the right. At most recent evaluation on 3/28/2016 he continues to have mild scapular winging when doing a wall pushup and has mild scapular dyskinesia with slow controlled shoulder abduction.  Full-strength with resisted internal and external rotation and supraspinatus testing, subcapsular slipped off test, shoulder flexion and abduction.  Full biceps and triceps strength.
Age: 17.0
Sex: F
Vaccine: HPV9
Symptoms: Discomfort, Lip blister, Oropharyngeal pain, Pain, Pruritus
Clinical narrative: Fever of 103 on Friday and Saturday evening May 20-21, Complained of body aches. Child came to clinic on Monday 05/23/2016 complaining of sore throat and blisters on lips. Follow up visit today no fever times 24 hours with less throat pain. She has new crust covered lesions to lower lip and fine papules to tongue. Itching and pustular with some discomfort. KEFLEX given today 05/25/16.
Age: 17.0
Sex: F
Vaccine: HPV9
Symptoms: Rash pustular, Scab, Tongue eruption
Clinical narrative: Fever of 103 on Friday and Saturday evening May 20-21, Complained of body aches. Child came to clinic on Monday 05/23/2016 complaining of sore throat and blisters on lips. Follow up visit today no fever times 24 hours with less throat pain. She has new crust covered lesions to lower lip and fine papules to tongue. Itching and pustular with some discomfort. KEFLEX given today 05/25/16.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia, Pruritus
Clinical narrative: Found bald spot on back of her head, scalp itchy for a few weeks.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia
Clinical narrative: LOSING HAIR.
Age: 19.0
Sex: F
Vaccine: HEP, VARCEL
Symptoms: Altered state of consciousness, Asthenia, Disorientation, Feeling abnormal, Head injury
Clinical narrative: Pt. had Varicella Vaccine & Hep. B Vaccine @ 0910am. While attempting to sit in waiting room she stated she felt funny like she was going to pass out. She went forward & hit her L Forehead on the wall. Was then assisted into chair. Rescue called, At that time she was disoriented, weak, pale & diaphoretic. She was able to answer what her name is. She then slumped over, became unresponsive for a few seconds...increased diaphoresis, noted that hands became clenched. Smelling Salts administered, ice pack applied to back of neck. Pt became responsive, able to answer questions appropriately. Pupils dilated to approx. 14mm. VS P-60, RR-12, BP-101/49, O2 Sat 97%. Rescue arrived, VSS,PERRLA @ 6mm, she stated she felt better and initially declined transport to ED. While waiting for ride...she stated that she was feeling worse & that her vision was "Wavy/Blurry" similar to an "Aura" she has had in the past with Migraines. Pupils again dilated to approx. 10mm. Denied headache & nausea. Rescue again called & she was transported to ED.